A detailed history of Chapman Investment Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Chapman Investment Management, LLC holds 2,695 shares of LLY stock, worth $2.44 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
2,695
Holding current value
$2.44 Million
% of portfolio
1.64%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $1.6 Million - $2.14 Million
2,695 New
2,695 $2.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Chapman Investment Management, LLC Portfolio

Follow Chapman Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chapman Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chapman Investment Management, LLC with notifications on news.